Search results
No One Is Buying the Biden Campaign’s Spin
Rolling Stone via Yahoo News UK· 5 days agoSince the debate last week, where Biden looked feeble and failed to complete his thoughts several times, he and his campaign have appeared unable, or...
Is Unity Biotechnology (NASDAQ:UBX) In A Good Position To Invest In Growth?
Simply Wall St. via Yahoo Finance UK· 4 days agoUnity Biotechnology didn't record any revenue over the last year, indicating that it's an early...
What fathers in the animal kingdom can tell us about humans
The Conversation via Yahoo News UK· 4 days agoHe may get injured during fights and spends most of his time defending his harem, reducing the time...
Spain’s unlikely Euro 2024 hero Mikel Merino - and the story of his special celebration
New York Times· 15 hours agoIt took an unexpected hero for Spain to beat a major tournament host for the first time in their...
What DOES happen if Rishi Sunak loses his seat on July 4?
Daily Mail· 6 days agoAnd it is what happens to the party in the days and weeks after a defeat that could define its...
Over 50% Of Hybrid Workers Admitted To Partaking In A New Controversial Office Trend, And This Is...
BuzzFeed via Yahoo News· 3 days agoThe latter can be a helpful attitude adjustment. “Try to reframe the coffee badging so that you feel...
NFL offseason power rankings: No. 21 Seattle Seahawks move onto Mike Macdonald era
Yahoo Sports· 4 days ago"I did not see them letting Pete go. "It was a situation where I expected them to let Pete coach as...
Opinion | L.B.J. Did It in 1968. Biden Can Do It, Too.
New York Times· 5 days agoMr. Boyle is the author of “The Shattering: America in the 1960s.” On March 31, 1968, Lyndon Johnson...
All the Gossip on the Biden Family’s Postdebate Blame Game
New York Magazine· 5 days agoDemocrats have been in full panic mode since Joe Biden’s disastrous debate performance against...
Companies Like Keros Therapeutics (NASDAQ:KROS) Are In A Position To Invest In Growth
Simply Wall St. via Yahoo Finance UK· 2 days agoHow Risky Is Keros Therapeutics' Cash Burn Situation? As you can probably tell by now, we're not too...